Observation on the clinical effect of Wenyun Decoction in the treatment of obese polycystic ovary syndrome based on Xu's theory of Fuyang

onghua Hospital Shanghai University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

试验速览

暂无简介。

•1. Meet the diagnostic criteria of western medicine for obese polycystic ovary syndrome;
•2. Comply with the syndrome differentiation standard of deficiency of kidney yang and mutual congestion of phlegm and blood stasis in TCM;
•3. The course of the disease is within 2 years;
•4. Patients (gender) between 18 and 35 years old;
•5. Patients who have signed an informed consent form.
•6. If the subject has used weight loss drugs (such as orlistat, liraglutide, etc.), anti-androgen drugs (Diane-35, spironolactone, etc.), ovulation induction within 1 month before being included in the study Drugs (clomiphene, etc.) can be included in this study after a 3-month drug wash-out period.

•1. Patients with mental illness and severe diseases such as cardiovascular, cerebrovascular, liver, and hematopoietic system;
•2. Allergic constitution, or pregnant or lactating women;
•3. Patients who participated in other clinical trials within the past 3 months;
•4. People with mental illness;
•5. Those with contraindications to metformin hydrochloride tablets.

发起方

onghua Hospital Shanghai University of Traditional Chinese Medicine